![Greg Misson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Greg Misson is currently the Managing Director at Eqalis Pharmaceuticals Ltd.
He previously worked as the Executive Director & Chief Innovation Officer at Cannasouth Ltd.
Postes actifs de Greg Misson
Sociétés | Poste | Début |
---|---|---|
Eqalis Pharmaceuticals Ltd
![]() Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Directeur Général | - |
Anciens postes connus de Greg Misson
Sociétés | Poste | Fin |
---|---|---|
CANNASOUTH LIMITED | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CANNASOUTH LIMITED | Health Technology |
Entreprise privées | 1 |
---|---|
Eqalis Pharmaceuticals Ltd
![]() Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Health Technology |